GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biovica International AB (OSTO:BIOVIC B) » Definitions » Additional Paid-In Capital

Biovica International AB (OSTO:BIOVIC B) Additional Paid-In Capital : kr577.64 Mil(As of Jan. 2025)


View and export this data going back to 2017. Start your Free Trial

What is Biovica International AB Additional Paid-In Capital?


Biovica International AB's quarterly additional paid-in capital increased from Jul. 2024 (kr559.18 Mil) to Oct. 2024 (kr577.42 Mil) and increased from Oct. 2024 (kr577.42 Mil) to Jan. 2025 (kr577.64 Mil).

Biovica International AB's annual additional paid-in capital increased from Apr. 2022 (kr340.05 Mil) to Apr. 2023 (kr463.94 Mil) and increased from Apr. 2023 (kr463.94 Mil) to Apr. 2024 (kr543.92 Mil).

Biovica International AB Additional Paid-In Capital Historical Data

The historical data trend for Biovica International AB's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biovica International AB Additional Paid-In Capital Chart

Biovica International AB Annual Data
Trend Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 195.13 338.76 340.05 463.94 543.92

Biovica International AB Quarterly Data
Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 544.00 543.92 559.18 577.42 577.64

Biovica International AB Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Biovica International AB Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Biovica International AB's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Biovica International AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biovica International AB (OSTO:BIOVIC B) » Definitions » Additional Paid-In Capital
Comparable Companies
OSTO:NXTCL OSTO:ACOU OSTO:ATORX OSTO:SPAGO OSTO:EXPRS2 OSTO:ONCOZ OSTO:PILA XSAT:NIDHOG OSTO:NICA XSAT:CHOSA VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
Dag Hammarskjolds vag 54B, Uppsala Science Park, Uppsala, SWE, 752 37
Website
https://www.biovica.com
Biovica International AB is a biotech company. The company develops and commercializes blood-based diagnostic tests with biomarkers that improve the monitoring and evaluation of modern cancer treatments. The company promotes healthcare through collaboration with cancer institutes and pharmaceutical companies. DiviTum is manufactured by the company and sold as a kit consisting of a reaction plate with reagents that have been optimized for ELISA applications.

Biovica International AB Headlines

No Headlines